Prospective Karyotype Analysis in Adult Acute Lymphoblastic Leukemia: The Cancer and Leukemia Group B Experience
作者： Michelle M. Le Beau , Krzysztof Mrózek , Ted P. Szatrowski , Clara D. Bloomfield , Meir Wetzler
DOI: 10.1182/BLOOD.V93.11.3983
关键词:
摘要: The Cancer and Leukemia Group B (CALGB) has been conducting a prospective cytogenetic companion study (CALGB 8461) to all CALGB treatment protocols for newly diagnosed …
ashpublications.org
bloodjournal.org参考文章(33)
Lee Yj, Simon R, Nonparametric confidence limits for survival probabilities and median survival time. Cancer treatment reports. ,vol. 66, pp. 37- 42 ,(1982)
Clara D. Bloomfield, Charles A. Linker, Bayard L. Powell, Stanley R. Frankel, Richard A. Larson, Frederick R. Davey, Richard M. Stone, Philip Schulman, Richard K. Dodge, Edward J. Lee, Stephen L. George, Charles A. Schiffer, A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood. ,vol. 92, pp. 1556- 1564 ,(1998) , 10.1182/BLOOD.V92.5.1556
J Cuttner, R J Mayer, E S Henderson, R Mick, R B Weiss, E J Lee, P A Paciucci, R Sobol, F Davey, D R Budman, Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB Study. Leukemia. ,vol. 5, pp. 425- 431 ,(1991)
Martin Carroll, Sayuri Ohno-Jones, Shu Tamura, Elisabeth Buchdunger, Jürg Zimmermann, Nicholas B. Lydon, D. Gary Gilliland, Brian J. Druker, CGP 57148, a Tyrosine Kinase Inhibitor, Inhibits the Growth of Cells Expressing BCR-ABL, TEL-ABL, and TEL-PDGFR Fusion Proteins Blood. ,vol. 90, pp. 4947- 4952 ,(1997) , 10.1182/BLOOD.V90.12.4947.4947_4947_4952
Stefan Faderl, Hagop M. Kantarjian, Moshe Talpaz, Zeev Estrov, Clinical Significance of Cytogenetic Abnormalities in Adult Acute Lymphoblastic Leukemia Blood. ,vol. 91, pp. 3995- 4019 ,(1998) , 10.1182/BLOOD.V91.11.3995.411A43_3995_4019
CA Linker, LJ Levitt, M O'Donnell, SJ Forman, CA Ries, Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report. Blood. ,vol. 78, pp. 2814- 2822 ,(1991) , 10.1182/BLOOD.V78.11.2814.2814
M Okabe, Y Kuni-eda, T Sugiwura, M Tanaka, T Miyagishima, I Saiki, T Minagawa, M Kurosawa, T Itaya, T Miyazaki, Inhibitory effect of interleukin-4 on the in vitro growth of Ph1-positive acute lymphoblastic leukemia cells. Blood. ,vol. 78, pp. 1574- 1580 ,(1991) , 10.1182/BLOOD.V78.6.1574.1574
NJ Chao, KG Blume, SJ Forman, DS Snyder, Long-term follow-up of allogeneic bone marrow recipients for Philadelphia chromosome-positive acute lymphoblastic leukemia [letter] Blood. ,vol. 85, pp. 3353- 3354 ,(1995) , 10.1182/BLOOD.V85.11.3353.BLOODJOURNAL85113353
M. Stockshläder, S. Hegewisch-Becker, W. Krüger, A. Dieck, M. Hoffknecht, C. Berger, B. Kohlschütter, H. Martin, S. Peters, H. Kabisch, R. Kuse, H. J. Weh, D. K. Hossfeld, A. Zander, Bone marrow transplantation for Philadelphia-chromosome-positive acute lymphoblastic leukemia Bone Marrow Transplantation. ,vol. 16, pp. 663- 667 ,(1995) , 10.1007/978-3-642-60377-8_107
David R. Cox, Regression Models and Life-Tables Springer Series in Statistics. ,vol. 34, pp. 527- 541 ,(1992) , 10.1007/978-1-4612-4380-9_37